Recently, Baiyun Mountain, which has the two "golden mountains" of "domestic small blue films" Jin Ge and Wang Laoji, has been publicly slapped in the face.
It is reported that Baiyunshan released a financial report to shareholders, saying that in the first three quarters of 2023, Baiyunshan's revenue and net profit attributable to the parent company will be 58.2 billion yuan and 3.8 billion yuan respectively, a slight increase year-on-year, and the situation is very good.
The voice did not fall, but it was publicly ridiculed by the financial **, bluntly saying that its market value is at the bottom of the industry, and the gross profit and net profit continue to be low, and the asset load rate has increased all the way to 51% in the first three quarters of 2023.
Baiyun Mountain was once known as "the first stock of domestic small blue films", why can't it rise now?
1. Shrink 12 million pieces, and the men collectively rejuvenate
As the first imitation of "Viagra" in China, Jinge has a gross profit margin of 9128%, known as the strongest "gold-absorbing beast" in Baiyun Mountain by the industry, comparable to Moutai. In 2021 alone, 9849 were sold820,000 tablets, with an account of nearly 1 billion yuan, surpassing the original drug and ranking first in the industry.
Relying on this "cornucopia", Baiyunshan shouted "small goals" and became the first health industry giant in China to enter the "100 billion market value club". But in recent years, this 20-year-old factory, known as the "golden gun does not fall", has suddenly become dumb.
Baiyunshan's financial report shows that since 2022, Jinge has encountered the first "cold winter" in a decade, with both production and sales declining, of which sales have decreased by nearly 12 million pieces compared with 2021. I thought that I would be able to turn the tide this year, but the growth in the third quarter was still weak.
CITIC** pointed out in the research reportIts core products do not sell because the market competition is too fierce.
In recent years, seeing that Jin Ge has made a lot of money by relying on "male source power", similar product manufacturers at home and abroad have taken action, hoping to get a share of the men's health market.
At the same time, a "Paivelo", nicknamed "men's gas station", also entered the domestic market. It is reported that it quickly got out of the circle because it created a one-night transaction of 8 million during the E-commerce Festival in November, and was named the "Little Blue Pump", and its popularity once exceeded that of domestic Jinge. Business intelligence data shows that since "Paiweiruo" entered China in 2022, there are many gimmicks about "helping men to last their own lasting power", and there is no shortage of people who buy 3 bottles at a time.
2. Unlock advanced gameplay, "all you buy is dignity".
Industry insiders said frankly,Behind men's enthusiasm for "little blue films" products, there is actually hidden pain.
In October 2022, data released by The Paper showed that the prevalence of ED in mainland China was as high as 4969%, which means that about half of men in China suffer from the problem of "carrying a gun into battle, but not being able to raise their heads".
But because it involves "hidden dignity", many people avoid talking about it. According to reports, the rate of ED visits was only 17% a few days ago. If you want to get out of the predicament and meet your partner's needs for "fun", you can only use products such as "little blue films".
The growing demand has ignited the "male power" market. According to Frost & Sullivan**, the size of China's men's health market is expected to reach RMB 99.6 billion by 2025. At the same time, the product pain points of "little blue films" have also been dug up one after another.
It is reported that following the advent of the domestic "Little Blue Film", because it can only meet the "temporary speed", it is still soft after one time, which makes men continue to rely on "medicine cannot be stopped". After aiming at the pain points of men, other manufacturers attacked one after another, and the above-mentioned "Paiviruo" was born here!
According to public information, unlike the "one-time boost" of the domestic "little blue film", "Paiviruo" directly targets the mitochondria, the source of male decline, the "cell energy factory", which has more scientific and technological attributes and can maintain male strength for a long time throughout the body.
Accordingly, the University of Tokyo and the Chinese Academy of Sciences have successively convened male volunteers aged 35-65 to carry out clinical trials, which have confirmed that under the intervention of the core of "Paiviruo", the signs of aging and decline such as muscular endurance, hair number, and essence value of volunteers have begun to approach the indicators of young adults. And this achievement has been included in the top international journals such as "Cell" and "Science".
Perhaps it is because of the experimental support and the high degree of overlap with the subject that "Paiviruo" is highly sought after by middle-aged men, even if it is as high as 4 figures. A single customer of the East D year reflected, "No matter how expensive it is, you have to buy it, it is related to the dignity of men, and you must not be sloppy." A few days ago, it was invited to enter the Expo, which has become a black technology that is vying to try.
Behind the huge profits and market demand, the capital has risen up, making the industry competition increasingly "white-hot".06%。
It is foreseeable that with the improvement of men's demand for "long-lasting maintenance, no worries". Gentle maintenance products such as "Paiviro" will further impact the market structure of this industry.
Third, the market potential is huge, and the chaos cannot be ignored
According to the data of the seventh national population census, the number of middle-aged men in China exceeds 300 million. At the same time, the commercial value of "Paiveruo" products is also gradually revealed, and the potential market for middle-aged groups, especially male users, is also becoming more and more broad. Baiyunshan has also gradually realized the shortcomings of its core business and is seeking new growth points.
However, the popularity of the market has also bred a series of industry chaos. According to relevant reports, some parts of the country have begun to appear in the lack of relevant qualifications of the three no-products, which is mostly exaggerated propaganda of its role.
"Pavillo's products are naturally extracted from plant ingredients, with uniform specifications, and have four safety testing certifications such as the US FDA GRAS and the European EFSA, so that men have "no worries", which may be more convincing. According to the data of Dongshang Intelligence, the repurchase rate of Paviruo products is as high as 639%, far exceeding the industry average.
The development of life science and technology should be the light of life to promote human health, not a money-making tool that creates chaos." In this regard, relevant institutions should also strengthen supervision and provide a healthy environment for the development of the male market.